New in MMWR: COVID-19 Rebound; COVID-19, Flu and RSV Vaccination Coverage and more

[Date Prev][Date Next][Thread Prev][Thread Next][Date Index][Thread Index]

MMWR banner

December 22, 2023

In this Issue


The figure is a photo of a clinician showing a clipboard to a patient with text about current evidence and COVID-19 rebound.

SARS-CoV-2 Rebound With and Without Use of COVID-19 Oral Antivirals

COVID-19 rebound was observed in people who did and did not receive antiviral treatment, and rebound symptoms typically appeared as a mild illness 3–7 days after the initial illness ended.

PDF of this issue (link)


This figure is a photo of police cars with flashing lights and caution tape.

A new, free CE from MMWR and Medscape discusses data on violent deaths reported from CDC’s National Violent Death Reporting System.


This figure is an image of a microphone on a dark background with sound waves and the text “MMWR Weekly Briefing,” representing the MMWR podcast.

MMWR Weekly Briefing Podcast: Week of December 4

The latest MMWR Weekly Briefing is live. Topics include: diagnosing tuberculosis in pregnant people at risk, updated recommendations for adult polio vaccination, and more. Listen and subscribe on: Apple Podcasts, Spotify, and Google Play.

Centers for Disease Control and Prevention

1600 Clifton Rd   Atlanta, GA 30329   1-800-CDC-INFO (800-232-4636)   TTY: 888-232-6348
Questions or Problems  | 

[Index of Archives]     [NIH News]     [FDA News]     [USDA News]     [Yosemite News]     [Steve's Art]     [SB Lupus]     [STB]
  Powered by Linux